Deblitorator
$XBIO Most traders haven't caught on to $XBIO. Their technology is designed to target NETs, which are implicated across multiple cancer types and treatment resistance pathways. Platform biotech + tiny float valuation = serious asymmetric setup when data comes through
1
13

:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_Getty_Images_2203138957_jpg_dd735f9905.webp)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault27.jpg)
:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault32.jpg)